Operating Expenses

Amortization of Intangible Assets (Unallocated)

Pfizer Amortization of Intangible Assets (Unallocated) decreased by 3.8% to $1.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.3%, from $1.21B to $1.18B. Over 4 years (FY 2021 to FY 2025), Amortization of Intangible Assets (Unallocated) shows an upward trend with a 7.1% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
Metric ID: pfe_amortization_of_intangible_assets_unallocated

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$917.00M$968.00M$957.00M$835.00M$822.00M$822.00M$1.13B$1.10B$1.18B$1.18B$1.27B$1.31B$1.31B$1.31B$1.36B$1.21B$1.21B$1.22B$1.23B$1.18B
QoQ Change—+5.6%-1.1%-12.7%-1.6%+0.0%+37.6%-2.5%+7.3%-0.4%+7.5%+3.2%-0.1%+0.4%+3.6%-10.9%+0.0%+1.0%+0.6%-3.8%
YoY Change————-10.4%-15.1%+18.2%+32.1%+44.0%+43.4%+12.0%+18.6%+10.4%+11.3%+7.3%-7.4%-7.3%-6.8%-9.5%-2.3%
Range$822.00M – $1.36B
CAGR+5.5%
Avg YoY Growth+8.7%
Median YoY Growth+8.8%

Frequently Asked Questions

What is Pfizer's amortization of intangible assets (unallocated)?
Pfizer (PFE) reported amortization of intangible assets (unallocated) of $1.18B in Q1 2026.
How has Pfizer's amortization of intangible assets (unallocated) changed year-over-year?
Pfizer's amortization of intangible assets (unallocated) decreased by 2.3% year-over-year, from $1.21B to $1.18B.
What is the long-term trend for Pfizer's amortization of intangible assets (unallocated)?
Over 4 years (2021 to 2025), Pfizer's amortization of intangible assets (unallocated) has grown at a 7.1% compound annual growth rate (CAGR), from $3.70B to $4.88B.